Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (281-290 of 364) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|November 3, 2009
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesSteven Black, Juhani Eskola, Claire-Anne Siegrist, et al.
Wellcome Open Research|January 8, 2026
Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus typeAnna Mensah, Rebecca Symes, Chengetai Mpamhanga, et al.
Lancet (London, England)|February 24, 2022
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionDaniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, et al.
The Lancet. Infectious Diseases|March 16, 2023
Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational studyMarta Bertran, Nick Andrews, Chloe Davison, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 26, 2019
Prevalence of new variants of <i>Chlamydia trachomatis</i> escaping detection by the Aptima Combo 2 assay, England, June to August 2019David J Roberts, Grahame S Davis, Michelle J Cole, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 6, 2015
Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15Richard G Pebody, Helen K Green, Nick Andrews, et al.
The Journal of Infectious Diseases|February 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant SublineagesTommy Nyberg, Katie Harman, Asad Zaidi, et al.
Research Involvement and Engagement|July 14, 2025
Developing a role for patients and the public in the implementation of health and social care research evidence into practice: the PIPER study (Pathways to Implementation for Public Engagement in Research) realist evaluation protocolSophie Staniszewska, Julia Walsh, Joe Langley, et al.
Influenza and Other Respiratory Viruses|August 18, 2021
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017Mary A Sinnathamby, Fiona Warburton, Nick Andrews, et al.
Vaccine|July 8, 2008
European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparationsAnna Giammanco, Antony Nardone, Richard Pebody, et al.
Pageof 37

Showing results (281-290 of 364) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|November 3, 2009
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesSteven Black, Juhani Eskola, Claire-Anne Siegrist, et al.
Wellcome Open Research|January 8, 2026
Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus typeAnna Mensah, Rebecca Symes, Chengetai Mpamhanga, et al.
Lancet (London, England)|February 24, 2022
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionDaniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, et al.
The Lancet. Infectious Diseases|March 16, 2023
Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational studyMarta Bertran, Nick Andrews, Chloe Davison, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 26, 2019
Prevalence of new variants of <i>Chlamydia trachomatis</i> escaping detection by the Aptima Combo 2 assay, England, June to August 2019David J Roberts, Grahame S Davis, Michelle J Cole, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 6, 2015
Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15Richard G Pebody, Helen K Green, Nick Andrews, et al.
The Journal of Infectious Diseases|February 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant SublineagesTommy Nyberg, Katie Harman, Asad Zaidi, et al.
Research Involvement and Engagement|July 14, 2025
Developing a role for patients and the public in the implementation of health and social care research evidence into practice: the PIPER study (Pathways to Implementation for Public Engagement in Research) realist evaluation protocolSophie Staniszewska, Julia Walsh, Joe Langley, et al.
Influenza and Other Respiratory Viruses|August 18, 2021
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017Mary A Sinnathamby, Fiona Warburton, Nick Andrews, et al.
Vaccine|July 8, 2008
European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparationsAnna Giammanco, Antony Nardone, Richard Pebody, et al.
Pageof 37